Fol. Biol. 2023, 69, 149-162

Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer

Ondřej Vít, Jiří Petrák

BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic

Received December 2023
Accepted December 2023

Autotaxin, also known as ecto-nucleotide pyrophosphatase/phosphodiesterase family member 2, is a secreted glycoprotein that plays multiple roles in human physiology and cancer pathology. This protein, by converting lysophosphatidylcholine into lysophosphatidic acid, initiates a complex signalling cascade with significant biological implications. The article outlines the autotaxin gene and protein structure, expression regulation and physiological functions, but focuses mainly on the role of autotaxin in cancer development and progression. Autotaxin and lysophosphatidic acid signalling influence several aspects of cancer, including cell proliferation, migration, metastasis, therapy resistance, and interactions with the immune system. The potential of autotaxin as a diagnostic biomarker and promising drug target is also examined.


This study was supported by the Czech Agency for Healthcare Research (NU23-01-00323), by the Ministry of Education, Youth, and Sports of the Czech Republic via Charles University (UNCE/ MED/016 and the Cooperatio programme, research area BIOLOGY), and by the National Institute for Cancer Research (Reg. No. LX22NPO5102) funded by the European Union – Next Generation EU, Programme EXCELES.


164 live references